A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC

Pablo García-González, Héctor Rodrigo Lara, Yaroslau Compta, Manuel Fernandez, Sven J. van der Lee, Itziar de Rojas, Laura Saiz, Celia Painous, Ana Camara, Esteban Muñoz, Maria J. Marti, Francesc Valldeoriola, Raquel Puerta, Ignacio Illán-Gala, Javier Pagonabarraga, Oriol Dols-Icardo, Jaime Kulisevsky, Juan Fortea, Alberto Lleó, Claudia OlivéSterre C.M. de Boer, Marc Hulsman, Yolande A.L. Pijnenburg, Rafael Díaz Belloso, Laura Muñoz-Delgado, Dolores Buiza Rueda, Pilar Gómez-Garre, Iban Aldecoa, Gemma Aragonés, Jorge Hernandez Vara, Maite Mendioroz, Jordi Pérez-Tur, Pieter Jelle Visser, Anouk den Braber, Janne M. Papma, Ángel Martín Montes, Eloy Rodriguez-Rodriguez, Josep Blázquez-Folch, Andrea Miguel, Fernando García-Gutiérrez, Amanda Cano, Sergi Valero, Marta Marquié, María Capdevila-Bayo, Maitee Rosende-Roca, Inés Quintela, Ángel Carracedo, Lluís Tàrraga, Luis M. Real, Jose Luis Royo, María Elena Erro, Carmen Guerrero, Daniela Corte Torres, Marta Blázquez-Estrada, Beatriz San Millán, Susana Teijeira, Dolores Vilas Rolan, Isabel Hernández, Antonio Sánchez-Soblechero, Beatriz de la Casa-Fages, Soledad Serrano López, Raquel Baviera-Muñoz, Amaya Lavín, Ricardo Taipa, Guillermo Amer, Elena Martinez-Saez, Marta Fernández-Matarrubia, Carmen Lage-Martínez, Victoria Álvarez, Laura Molina-Porcel, Henne Holstege, Pablo Mir, Olivia Belbin, Mercè Boada, Victoria Fernández, María J. Bullido, Alberto Rábano, Pascual Sánchez-Juan, Agustín Ruiz

Research output: Contribution to journalArticlepeer-review

Abstract

Progressive supranuclear palsy (PSP) is a rare 4-repeat tauopathy that causes behavioural, movement and cognitive abnormalities. We genotyped all available clinical and histopathological PSP cases in Spain and Portugal (N = 522), and conducted the largest PSP GWAS of the Iberian population to date. Genetic burden analysis revealed reduced diagnostic specificity in clinically diagnosed atypical PSP cases—when applying the 2017 MDS criteria—compared to Richardson’s syndrome cases. We independently replicated eight PSP risk variants in seven known loci (MAPT, MOBP, EIF2AK3, STX6, SLCO1A2, DUSP10 and APOE), and identified a novel locus in NFASC/CNTN2 (rs12744678 C: OR[95%CI] = 0.83[0.78–0.89]; p = 4.15·1008) after meta-analysis with a newly available Dutch cohort and publicly available summary statistics (3,099 PSP; 11,482 controls). Enrichment analysis and protein expression profiling highlighted oligodendrocyte function and myelination as likely contributors to PSP pathogenesis. Our findings broaden the genetic landscape of PSP and suggest potential therapeutic avenues focused on modulating neuron–oligodendrocyte interactions.

Original languageEnglish (US)
Pages (from-to)960-965
Number of pages6
JournalEuropean Journal of Human Genetics
Volume33
Issue number7
DOIs
StatePublished - Jul 2025

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'A Spanish-Portuguese GWAS of progressive supranuclear palsy reveals a novel risk locus in NFASC'. Together they form a unique fingerprint.

Cite this